Teti A, Volleth G, Carano A, Zambonin Zallone A
Istituto di Anatomia Umana Normale, Universitá di Bari, Italy.
Calcif Tissue Int. 1988 May;42(5):302-8. doi: 10.1007/BF02556364.
3H-thymidine-labeled blood monocytes were cultured with osteoclasts in the presence or absence of parathyroid hormone or 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in order to evaluate (1) the percentage of monocytes capable of fusing with osteoclasts, (2) if parathyroid hormone or 1,25(OH)2D3 influences the contribution of blood monocytes to osteoclast nuclear turnover. We found that within 24 hours of culture, about 8% of blood monocytes fuse with osteoclasts regardless of the presence of parathyroid hormone (PTH) or 1,25(OH)2D3. On the other hand, formation of non-osteoclastic giant cells by fusion of monocytes is enhanced by 5 x 10(-9) M 1,25(OH)2D3 but only in the presence of the bone resorptive cells.
将用³H-胸腺嘧啶核苷标记的血液单核细胞与破骨细胞一起培养,分别添加或不添加甲状旁腺激素或1,25-二羟基维生素D3(1,25(OH)₂D₃),以评估:(1)能够与破骨细胞融合的单核细胞百分比;(2)甲状旁腺激素或1,25(OH)₂D₃是否影响血液单核细胞对破骨细胞核更新的贡献。我们发现,培养24小时内,无论是否存在甲状旁腺激素(PTH)或1,25(OH)₂D₃,约8%的血液单核细胞会与破骨细胞融合。另一方面,单核细胞融合形成非破骨细胞性巨细胞的过程会被5×10⁻⁹ M的1,25(OH)₂D₃增强,但仅在存在骨吸收细胞的情况下。